Avidity Biosciences

$22.18 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Avidity Biosciences

Avidity Biosciences LLC operates as a biotechnology company. The Company develops and discovers novel antibody oligonucleotide conjugates therapeutics that overcome current barriers to the delivery of oligonucleotides and unlock their potential to treat a wide range of serious diseases. Avidity Biosciences serves customers in the United States.

Stock Analysis

last close $22.18
1-mo return -6.4%
3-mo return -4.5%
avg daily vol. 179.67T
52-week high 36.02
52-week low 17.58
market cap. $981M
forward pe -
annual div. -
roe -26.2%
ltg forecast -
dividend yield -
annual rev. $9M
inst own. 85.6%
baraka

Subscribe now for daily local and international financial news

Subscribe